We believe that our NanoPortal implants under development, including NPM-139, could address a growing segment of patients who would prefer a convenient once- or twice-yearly treatment option and the peace of mind that treatment could be stopped at any time if that became necessary. Separately, Vivani expects to initiate a Phase 1, randomized, first-in-human study evaluating the NPM-139 semaglutide implant, with Wegovy injections as an active comparator, in mid-2026
How can genetic testing help optimize my semaglutide schedule
Becaria A, Campbell A, Bondy SC
Otros ingredientes de nuestros masticables Heart + Vitality Otro aspecto interesante de la L-Carnitina es que sus compuestos pueden ofrecer numerosos beneficios al trabajar juntos
GHK Copper Peptide for Skin and Hair Copper peptides are a new and exciting trend in hair and skin care
Time2026-07-07 Tirzepatide is a GIP/GLP-1 dual-receptor agonist developed by Eli Lilly